formation. Partially purified coagulases were prepared, and were used to produce rabbit anticoagulase antisera. In vitro phagocytic studies, with the two staphylococcal strains plus rabbit polymorphonuclear peritoneal exudate cells and the various types of rabbit antisera, did not yield evidence that coagulase per se contributes to staphylococcal resistance to either ingestion or intracellular killing. The role of coagulase, if any, in the virulence of these organisms for rabbits (and probably for man) must therefore be attributed to some other mechanism.
The mechanism by which coagulase may contribute to the virulence of Staphylococcus aureus was the subject of numerous investigations. Hale and Smith (1945) , Smith, Hale, and Smith (1947) , and Davies (1951) suggested that coagulase induces a fibrin barrier in lesions, thus partially protecting the infecting organisms from phagocytosis. Ekstedt and Nungester (1955) noted that, whereas coagulase-positive staphylococci grew well in undiluted human serum, coagulase-negative organisms did not. The addition of partially purified coagulase to staphylococcus-serum mixtures was observed to permit growth of coagulasenegative staphylococci (Ekstedt 1956a, b) in undiluted human serum. The active principle in serum is apparently an alpha-2 globulin which, in addition to its lethal and lytic effects on S.
1 Present address: Letterman General Hospital, San Francisco, Calif. aureus, is able to inhibit glucose oxidation (Yotis and Ekstedt, 1960) . Fletcher (1962) was unable, however, to confirm that the addition of coagulase abolished the growth-inhibitory effect of the serum factor. Cohn and Morse (1959) studied the role of rabbit-immune sera prepared against coagulase-positive staphylococci, and found that the rate of ingestion of these organisms by rabbit polymorphonuclear leukocytes increased in the presence of the immune sera. In normal-rabbit serum, coagulase-positive strains were not efficiently ingested, although the coagulase-negative strains were rapidly engulfed. Mackaness (1960) reported similar findings with rabbit macrophages.
On the other hand, Foster (1962a) found that S. aureus strains which did not produce a coagulase specific for guinea-pig plasma were no less resistant to phagocytosis in vivo by cells of the guinea-pig reticuloendothelial system, and were no more susceptible to killing by heparinized blood in vitro than were strains producing this coagulase. All of his strains produced coagulases that were specific for human plasma. He further showed that the ability of S. aureus strains to multiply in vivo in guinea-pig kidney tissue was not correlated with their coagulase activity with guinea-pig plasma (Foster, 1962b) .
In view of these observations, it seemed of interest to ascertain whether coagulase production per se might be accountable for the resistance of S. aureus to phagocytosis, or whether its elaboration might be correlated with the formation of another cellular product which is actually responsible for the antiphagocytic effect. An in vitro phagocytic system, containing rabbit polymorphonuclear leukocytes from peritoneal exudate, plus coagulase-positive staphylococci and rabbit antiserum to one of the following, was employed: (i) partially purified free staphylocoagulase; (ii) heat-killed, coagulase-positive staphylococci grown under conditions favoring elaboration of free coagulase; and (iii) heat-killed, coagulase-positive staphylococci grown under cultural conditions where no detectable coagulase was formed. The agglutinating and coagulaseneutralizing activities of these antisera, as well as their ability to opsonize viable staphylococci in vitro, were determined.
MATERIALS AND METHODS
Staphylococcal strains. John E. Blair, Hospital for Joint Diseases, New York, N.Y., kindly furnished S. aureus strains of bacteriophage types 81 and 42D. As inocula, multiple small samples of these organisms were maintained in broth at -20 C or in lyophilized ampules.
Growth medium. To Brain Heart Infusion dialysate (BHID) broth (Fahlberg and Marston, 1960) lithium chloride was added to a 0.5% concentration to inhibit the formation of bound coagulase, as suggested by Barber (1955) . When cells were to be grown without free coagulase formation, the medium, normally containing 0.017 % glucose, was supplemented with additional glucose to a 1.0 % final concentration.
Preparation of antisera vs. whole cells. Vaccines were prepared according to the method of Weld and Rogers (1960) from washed cells grown either in the low-glucose medium (with coagulase formation) or in the glucose-supplemented medium (without coagulase formation). Sterilization was accomplished by heating the suspension at 60 C for 1 hr on 3 successive days. Vaccine (1010 cells per ml) was administered intravenously to male albino rabbits, weighing 4 to 5 kg, in doses of 0.2 ml on day 1, 0.4 ml on day 8, 0.6 ml on day 15, 0.8 ml on day 22, and 1.0 ml on day 29. The animals were bled on day 36 by cardiac puncture. All sera were heated at 56 C for 30 min and stored at 5 C.
Preparation of antisera vs. coagulase. Partially purified coagulase was prepared according to the procedure of Tager (1948) from cultures of each staphylococcal strian grown for 48 hr at 37 C in BHID. The lyophilized products (Borchardt, Pierce, and Shaffer, 1963) were stored in evacuated desiccators at 5 C. For immunization, 4 mg of coagulase, dissolved in 1.0 ml of 0.01 M phosphate buffer (pH 7), and homogenized in 0.5 ml of Freund incomplete adjuvant (Difco), was injected intramuscularly into rabbits each week for 6 weeks. The sera collected from cardiac bleeding 10 days after the last injection were heated at 56 C for 30 min and stored at 5 C.
Determination of coagulase and anticoagulase activity. To a series of tubes containing decreasing amounts of coagulase (in 0.5 ml of buffer) was added the clotting mixture, consisting of 0.5 ml of buffer containing 0.1% (w/v) bovine fibrinogen (Nutritional Biochemicals Corp., Cleveland, Ohio) and 0.1% (v/v) fresh human serum. After 3 hr of incubation at 37 C, the least amount of coagulase producing a turgid clot was considered to be the minimal clotting dose (MCD). The neutralization test was performed by adding 0.2 ml of serial twofold dilutions of antiserum in buffer to one MCD of coagulase in 0.2 ml of buffer. After 30 min of incubation at 37 C, 0.5 ml of clotting mixture was added to each tube, and readings were made after an additional 3 hr of incubation. The highest dilution of antiserum completely inhibiting fibrin formation was considered to be its anticoagulase titer.
Adsorption of antisera. A given serum sample was treated with one-tenth its volume of heatkilled, packed, washed cells. The mixture was incubated at 37 C for 30 min and at 5 C for 18 hr, after which it was centrifuged and the supernatant serum was removed. This procedure was performed three times.
In vitro phagocytic studies. Rabbit peritoneal exudates rich in polymorphonuclear leukocytes were obtained by glycogen stimulation, according to the method of Hirsch (1956) . Not more than 30 min were allowed to elapse between the time of collection of the exudate and its use. The procedure of Cohn and Morse (1959) (Table  1 ). The total viable population decreased only 28%, and, on the basis of data pertaining to viable intra-and extracellular organisms, only 8.3% of the total surviving cells were located intracellularly. On the other hand, in the presence of rabbit antiserum, there was a larger reduction in total viables over the 3-hr period, accompanied by extensive phagocytosis. This effect seemed to be independent of the nature of the immunizing agent which had been used to produce the antiserum and was not correlated with the presence or absence of coagulase-neutralizing antibodies. For example, in the system containing anticoagulase antibodies, the total viable population decreased 90% in 3 hr, at which time about 19% of the total remaining viables were intracellular. With antiserum to whole cells which had not produced coagulase, there was a 96% reduction in total viables in 3 hr; 19% of those remaining (total) were situated intracellularly.
Similar results were obtained in other experiments with the second strain of S. aureus (Table  2 ). In addition, the adsorption of anticoagulase and anti-whole cell antisera with washed homologous cells (which had produced coagulase during growth) largely removed their opsonizing properties (Table 2) . Coagulase-neutralizing activity remained, however, in the anticoagulase antiserum. It should be noted that only one phagocytic experiment was performed with each of the two adsorbed antisera, and that, in the 3-hr data pertaining to the absorbed anticoagulase serum, there is a major discrepancy in the figures for total bacteria found vs. the sum of intra-and extracellular bacteria recovered. Nevertheless, whether the total count or the sum of intra-and extracellular bacteria is used, a loss of opsonizing power from the antiserum after absorption is indicated.
It was observed that at 3 hr there often were fewer viable intracellular bacteria in the systems containing antiserum than in those containing normal serum. That the antisera were actively promoting phagocytosis, however, was shown by the rapid decline in the total and extracellular viable counts which usually occurred when antiserum was present. The occurrence of higher intracellular counts in the presence of normal serum could be explained if it were assumed that some of the bacteria counted were adherent extracellularly to leukocytes and that, in the presence of antiserum, ingestion and killing of bacteria was a continuing process during the 3-hr incubation period.
DISCUSSION
The experimental results were analyzed for significance with the Spearman rank correlation coefficient (Siegel, 1956) . The bactericidal effect of the average leukocyte was calculated. Consolidating all observations, there was a significant rank correlation (P = 0.01) demonstrable between the ratio of bacteria to leukocytes and the bactericidal effect of an average leukocyte in the presence of normal serum. This is in agreement with the report of Melly, Thomison, and Rogers (1960) , who found that intracellular killing of staphylococci was proportional to the bacteriumleukocyte ratio. This correlation could not be demonstrated for the additional portion of the bactericidal effect related to either antiwhole cell antibodies or anticoagulase antibodies. The effects of antiserum vs. whole cells and of antiserum vs. coagulase were approximately the same. No difference was noted between the effect of antiserum to coagulase-producing and to coagulase-nonproducing cells of the same strain.
All antisera tested increased the rate of phagocytosis and destruction of the coagulase-producing staphylococci. Although antiserum to whole cells did not neutralize coagulase, it was as effective as anticoagulase antiserum in promoting phagocytosis. Therefore, it appears unlikely that the phagocytosis-promoting action of anticoagulase antiserum is related to its coagulase-neutralizing ability. This finding does not support the hypothesis that coagulase in some way permits staphylococci to escape phagocytosis.
Because anticoagulase antiserum not only neutralized coagulase but also agglutinated staphylococcal cells, it apparently contained antibodies to surface cellular components as well as antibodies specifically reactive with coagulase. Such antibodies, doubtlessly, were also responsible for its opsonizing properties. It follows that the coagulase preparations were contaminated with PHAGOCYTOSIS OF S. A UREUS cellular components, in agreement with our data -obtained from immunodiffusion studies with coagulase and cellular extracts (Borchardt et al., 1963) . Whether the contaminating material includes the heat-stable protective antigen *of S. aureus described by Fisher (1960) , or the phagocytosis-inhibiting substance obtained by Morse (1962) from the Smith strain of S. aureus, remains to be determined.
In these experiments, therefore, evidence was -not obtained to support the hypothesis that coagulase contributes to staphylococcal resistance to phagocytosis by rabbit leukocytes. Furthermore, the data did not suggest that coagulase contributes to staphylococcal survival within leukocytes, because a more rapid loss of viable intracellular staphylococci in the presence of anticoagulase antiserum, compared with that in -its absence, was not observed.
